1. Home
  2. CYTK vs KBH Comparison

CYTK vs KBH Comparison

Compare CYTK & KBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • KBH
  • Stock Information
  • Founded
  • CYTK 1997
  • KBH 1957
  • Country
  • CYTK United States
  • KBH United States
  • Employees
  • CYTK N/A
  • KBH N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • KBH Homebuilding
  • Sector
  • CYTK Health Care
  • KBH Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • KBH Nasdaq
  • Market Cap
  • CYTK 4.6B
  • KBH 4.6B
  • IPO Year
  • CYTK 2004
  • KBH 1987
  • Fundamental
  • Price
  • CYTK $49.76
  • KBH $65.37
  • Analyst Decision
  • CYTK Buy
  • KBH Hold
  • Analyst Count
  • CYTK 15
  • KBH 13
  • Target Price
  • CYTK $75.57
  • KBH $67.88
  • AVG Volume (30 Days)
  • CYTK 2.7M
  • KBH 1.2M
  • Earning Date
  • CYTK 11-05-2025
  • KBH 09-24-2025
  • Dividend Yield
  • CYTK N/A
  • KBH 1.53%
  • EPS Growth
  • CYTK N/A
  • KBH 0.49
  • EPS
  • CYTK N/A
  • KBH 7.59
  • Revenue
  • CYTK $85,738,000.00
  • KBH $6,673,869,000.00
  • Revenue This Year
  • CYTK $330.96
  • KBH N/A
  • Revenue Next Year
  • CYTK $73.41
  • KBH N/A
  • P/E Ratio
  • CYTK N/A
  • KBH $8.59
  • Revenue Growth
  • CYTK 2635.74
  • KBH 3.65
  • 52 Week Low
  • CYTK $29.31
  • KBH $48.90
  • 52 Week High
  • CYTK $59.39
  • KBH $89.70
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 63.01
  • KBH 56.48
  • Support Level
  • CYTK $49.22
  • KBH $64.27
  • Resistance Level
  • CYTK $53.58
  • KBH $67.52
  • Average True Range (ATR)
  • CYTK 2.54
  • KBH 1.53
  • MACD
  • CYTK 0.29
  • KBH -0.21
  • Stochastic Oscillator
  • CYTK 76.53
  • KBH 48.06

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

Share on Social Networks: